Business Daily Media

Men's Weekly

.

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

  • Written by ACN Newswire

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

- Trial achieved its primary endpoint of pathological Complete Response Rate- Trial achieved its secondary endpoint in operability (R0 rate)- NBTXR3 demonstrated significant superiority and clinical benefits for patients versus standard of care- Safety profile confirmed- Randomized trial validated the first-in-class mode of action of NBTXR3Paris,...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

The Next Generation of Maritime Sustainable Solutions

As organizations globally seek innovative ways to improve sustainability and their impact on Earth, the American Waterways Operators (AWO), a lead...

Demand for Home Batteries surges as Federal Rebate Kicks In

A leading provider of energy solutions VoltX Energy has seen a 400% increase in demand for home batteries in the past three weeks as people put d...

Why Sport Remains the Safest Bet in an Uncertain World

When Rome was in crisis, its leaders did not retreat to the Senate. They went to the circus. To the chariot races. To the gladiators. Sport was no...

Sell by LayBy